A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. - Wikidata - awgldk - TriplyDB

A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.

A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.

http://www.wikidata.org/entity/Q39737420

about

Cellular and molecular mechanisms of fibrosis Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis Chemokines and Chemokine Receptors in the Development of Lupus Nephritis Macrophages promote renal fibrosis through direct and indirect mechanisms Molecular mechanisms of diabetic kidney disease Functional genomic annotation of genetic risk loci highlights inflammation and epithelial biology networks in CKD Macrophages and immunologic inflammation of the kidney.Inhibition of infection-mediated preterm birth by administration of broad spectrum chemokine inhibitor in mice.Chemokine receptor Ccr1 drives neutrophil-mediated kidney immunopathology and mortality in invasive candidiasis Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy.New therapeutics that modulate chemokine networks.In vivo bradykinin B2 receptor activation reduces renal fibrosis.Therapeutic targeting of CCR1 attenuates established chronic fungal asthma in mice.Therapeutic targets for treating fibrotic kidney diseases The chemokine, CCL3, and its receptor, CCR1, mediate thoracic radiation-induced pulmonary fibrosis.Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse.Fibrotic disease and the T(H)1/T(H)2 paradigm.Cellular and molecular mechanisms of renal fibrosis.Myeloid cell-derived hypoxia-inducible factor attenuates inflammation in unilateral ureteral obstruction-induced kidney injury Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice CCR1 antagonists in clinical development.A20 regulates IL-1-induced tolerant production of CXC chemokines in human mesangial cells via inhibition of MAPK signaling Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction.Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kappaB signaling Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury.Novel actions of tissue-type plasminogen activator in chronic kidney disease.CCR1 and CCR5 promote hepatic fibrosis in mice Efficient renal recruitment of macrophages and T cells in mice lacking the duffy antigen/receptor for chemokines.Obstructive renal injury: from fluid mechanics to molecular cell biology Chemokine receptor antagonists: Part 1.Antifibrosis: to reverse the irreversible.Cytokines, atherogenesis, and hypercatabolism in chronic kidney disease: a dreadful triad.CD11c⁺ CD8⁺ T Cells Reduce Renal Fibrosis Following Ureteric Obstruction by Inducing Fibroblast Apoptosis.Broad-Spectrum Inhibition of the CC-Chemokine Class Improves Wound Healing and Wound Angiogenesis.Fibrogenesis in kidney transplantation: potential targets for prevention and therapy.Oxidative stress in obstructive nephropathy.Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue.Therapeutic potential of CCR1 antagonists for multiple myeloma.Immunotherapy for acute kidney injury.

P2860

Q24648892-959D6EFC-DD9C-4361-9049-43A3E6213F66 Q24649584-6D0F3081-D5D4-44BF-9AE7-CD142BA4184C Q26741199-E9459B0A-B938-42D9-9EB2-0373987C53F3 Q26796635-8FFA814D-53CC-4F96-B4A7-46C956270FC7 Q27003963-F3F7E42B-1A58-4DFD-9601-6525D47E3E2A Q28854580-8E606908-6D91-41BB-9C11-332E81055A6F Q34067326-8E9A50D3-6078-40F8-AADD-A1EE1AD4D2F6 Q34336857-82808CEE-DDFC-483F-B1AB-0E390B7F5193 Q34390535-AE2B1DBE-403B-4FB2-A324-694D146A851B Q34667755-596539E7-6051-4C47-A8ED-74E6CB563EFC Q34743328-C60091FF-369E-4A96-9669-4A6BA857DF49 Q34795075-EB6579AD-9211-4776-A380-9BE2700B6DCC Q35049062-38F9E867-2E85-4BD0-B461-4AA8BD0D2997 Q35079607-83693332-99E2-4ED1-BA82-8F4EAFAF6734 Q35132169-C9E51097-0CFE-422F-AA8D-0FF12B453C48 Q35570438-03E61C6B-C223-4859-9674-D7EC1C2A9C07 Q35852270-583C953B-F4ED-4C7D-8E34-EDCE9636592C Q35903772-F8BCEB5C-5DE7-4D66-8FD8-0B74FC4D3509 Q35936151-21842562-84DC-4095-A9C1-EA1C0DB8877B Q35963225-644770D5-998B-4ED8-82A2-AB6D20995302 Q36196440-F9113BD1-BBCE-456E-8C4B-777250A621D7 Q36357425-8CB8D072-7549-49FA-8397-7470DA643FBB Q36560836-2FCC2861-5229-4CD7-8BC5-28703E8B4B68 Q36734848-422E929A-BD1C-4F74-A322-F48DFA19BB9C Q36842418-C2DF0887-3B51-4A3F-99F6-BC5CF6DC5AB5 Q37079501-01C700FB-AB2F-439E-B874-BB6A05E3C9F7 Q37115034-4BD36B13-E268-4B7E-AE71-C8351104782E Q37241370-B8999BF9-0777-473F-B193-FBD1EF4AC4CB Q37257139-F3730DD2-8275-420D-B8AA-0124F9B27A18 Q37283558-AFC9EB4C-ACC4-4B71-9C31-25AE6C163FD9 Q37481238-A4E6E821-0D79-4AD1-857E-6554CE0E7ADB Q37528202-CFCC8482-310F-4F3E-8586-B56CB9DE843E Q37587296-DAC634BC-684A-40DD-8E4F-EDB0647A3425 Q37631372-CB152204-3521-487C-B693-9E14C90EA66B Q37631612-AA3786F0-E81E-4DF9-A942-ED92504B9E35 Q37638064-1F8842BD-EB07-48AD-9A76-F15E9E19A152 Q37784045-3A765883-861C-485F-BD26-0BBE2F0A9C54 Q37848921-5A1B5B42-C376-4FEF-B753-244143EEF3CE Q37948866-4E81F47D-56C3-42C9-BA68-C98813FBB29D Q37991781-4544D218-90DF-45C8-A23A-0947274AD9E5

P2860

A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.

http://www.wikidata.org/entity/Q39737420

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

A chemokine receptor CCR-1 ant ...... er unilateral ureter ligation.

@en

A chemokine receptor CCR-1 ant ...... er unilateral ureter ligation.

@nl

type

label

A chemokine receptor CCR-1 ant ...... er unilateral ureter ligation.

@en

A chemokine receptor CCR-1 ant ...... er unilateral ureter ligation.

@nl

prefLabel

A chemokine receptor CCR-1 ant ...... er unilateral ureter ligation.

@en

A chemokine receptor CCR-1 ant ...... er unilateral ureter ligation.

@nl

P1433

Q39737420-A74E8396-94F0-4007-B294-43DC7D985D54

P1476

Q39737420-039F4D5B-9587-4180-A875-50A79D65921D

P2093

Q39737420-0AA1AD2B-ED1A-4F65-AEAB-15C59912A9FE

Q39737420-0F49CB7D-5D01-421D-9974-858458476399

Q39737420-1CE1478A-6A81-44EC-9A5A-61110102FFCD

Q39737420-3EC0945A-0298-4E2D-8487-D4B0AA4D2C91

Q39737420-44772B33-B0FB-42A3-8645-AD124D857233

Q39737420-48E4E7A3-9979-4945-A867-E292725D68F7

Q39737420-51051AD0-75CE-48CC-A069-489B4B9F3503

Q39737420-83EE7556-DED9-4C23-A30E-00DD59C32DE0

Q39737420-A4E20031-6D9B-455E-8998-A3D44E94C5F3

Q39737420-A9B0E0C7-76AB-44BB-B22E-90A8AD83F347

P2860

Q39737420-01B17091-4C95-484E-A8AF-55FA429CD306

Q39737420-05A76B40-43EA-4562-944B-0E1C5D795EB5

Q39737420-05E64269-6094-48B8-9AAA-2DE327C814FD

Q39737420-12439601-E1C2-45AC-A5B2-F6997A36FA36

Q39737420-1545657F-E340-470E-8385-8F05A1DA1DE8

Q39737420-2B894377-EF1E-48E8-9796-6592F23FCA7C

Q39737420-479DC896-06C1-4586-84A4-9773505EF8ED

Q39737420-4F20AEB3-B739-4904-96E8-68B1947D4D60

Q39737420-50D8D176-D5A0-4CB9-882E-0DD2CCCC2D1F

Q39737420-61108BD4-E002-415C-8DB8-9D2820158D99

P304

Q39737420-26A9268A-FCFF-4911-90D3-F8ECAF1C16B6

P31

Q39737420-5415B182-7891-45BF-87AB-A15975862BBB

P356

Q39737420-BA3303ED-91F3-42CD-9EFC-F8579451DA28

P407

Q39737420-34B53CFA-CD0D-4B87-9E63-59C5BD784AF6

P433

Q39737420-57085629-07B1-4EF2-86AB-0E5F41FFE3A0

P478

Q39737420-4D76A886-9DCF-4688-831A-2DA9D35C4EF9

P577

Q39737420-83BF1691-1784-49F6-8035-9A387F33A4C8

P698

Q39737420-EA7F1265-987D-4A36-BA1E-90BA85AD4696

P932

Q39737420-38CFB5D0-EB4E-4AE9-9DE7-7564846AE528

P356

P1433

Journal of Clinical Investigation

P1476

A chemokine receptor CCR-1 ant ...... er unilateral ureter ligation.

@en

P2093

Clemens D Cohen

http://www.w3.org/2001/XMLSchema#string

Detlef Schlöndorff

http://www.w3.org/2001/XMLSchema#string

Frank Strutz

http://www.w3.org/2001/XMLSchema#string

Hans-Joachim Anders

http://www.w3.org/2001/XMLSchema#string

Hermann-Josef Gröne

http://www.w3.org/2001/XMLSchema#string

James Onuffer

http://www.w3.org/2001/XMLSchema#string

Matthias Kretzler

http://www.w3.org/2001/XMLSchema#string

Matthias Mack

http://www.w3.org/2001/XMLSchema#string

Michael Frink

http://www.w3.org/2001/XMLSchema#string

Peter J Nelson

http://www.w3.org/2001/XMLSchema#string

P2860

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

International union of pharmacology. XXII. Nomenclature for chemokine receptors

Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1

Chemokines: a new classification system and their role in immunity

Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies.

The role of tubulointerstitial injury in chronic renal failure.

Expression of chemokines and chemokine receptors during human renal transplant rejection.

Role of fibroblast activation in inducing interstitial fibrosis.

Renal fibrosis: an update.

Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha.

P304

251-259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI0214040

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11805137

http://www.w3.org/2001/XMLSchema#string

P932

150841

http://www.w3.org/2001/XMLSchema#string